Home > Award > Award

Award

Note: The award owner's name is highlighted with blue.

Award in 2015
  1. Liang C.One-year studentship provided by the “Mr. Kwok Yat Wai and Madam Kwok Chung Bo Fun Graduate School Development Fund”, 2015.
  2. Liang C., Guo B, Wu H, Zhang L, Lu A, Zhang G. Aptamer-functionalized delivery system for osteogenic siRNAs to achieve osteoblast-specific RNA interference for bone anabolic therapy. 2015 Orthopaedic Research Society (ORS) annual meeting, Las Vegas, March 28-31, 2015. Certificate.
  3. Liu J, Dang L, Li D, Guo B, Lu A, Zhang G. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of miRNAs in osteoclasts. Poster Abstract, Young Investigator Award, ICMRS Conference and Xiangya Osteoporosis Forum, Changsha, China, Apr 9-11, 2015. Certificate
  4. Liang C., Xu M, Xu J, Zhang B, Lu A, Zhang G. Discovery of Small Molecules to Promote BMP Signaling and Bone Formation. 6th Sino-American Symposium on Clinical and Translational Medicine (SAS-CTM). Abstract. Clinical and Translational Medicine Excellent Thesis Awards.
  5. Liang C., ASBMR Young Investigator Award for the European Calcified Tissue Society (ECTS) Ph.D. Training Course. University of Siena, Tuscany, Italy. September 13-16, 2015.

Award in 2014
  1. Zhang Ge. Investigation of regulatory mechanism of ubiquitin ligases and their application in the treatment of osteoporosis. Chinese Medical Science and Technology Award. (Second class). 2014.
  2. Zhang Ge. Investigation of molecular function, regulatory mechanism and disease correlation of ubiquitin ligases. Beijing Science and Technology Awards (First class). 2014. Certificate.
  3. Zhang Ge. Modernization of traditional anti-osteoporosis Chinese medicine. National Science & Technology Progress Award (Second class). 2014. Certificate.
  4. Liang C, Guo B, Wu H, Zhang L, Lu A, Zhang G. Aptamer-Functionalized Lipid Nanoparticles (LNPs) Targeting Osteoblasts as a Novel RNA Interference-Based Bone Anabolic Strategy. ASBMR 2014 Annual Meeting. Oral Presentation Abstract. Young Investigator Award. September 12-15, 2014.
  5. Liang C, Guo B, Wu H, Zhang L, Lu A, Zhang G. Aptamer-Functionalized Lipid Nanoparticles (LNPs) Targeting Osteoblasts as a Novel RNAi-Based Bone Anabolic Strategy. 5th Sino-American Symposium on Clinical and Translational Medicine (SAS-CTM). Abstract. Clinical and Translational Medicine Excellent Thesis Awards.
  6. Dang L, Guo B, Li D, Lu A, Zhang G. A Peptide-functionalized delivery system to target osteoclasts. ASBMR 2014. Poster Presentation Abstract. Young Investigator Travel Grant Award. September 11-15, 2014.
  7. Baosheng Guo, Liu Jin, Dang lei, Liang Chao, Xiaohua Pan, Lingqiang Zhang, Aiping Lu, Baoting Zhang, Ge Zhang. Up-regulated CKIP-1 expression within osteoblasts associates with reduced BMP signaling and decreased bone formation during aging, The excellent thesis award. The 5th Sino-American Symosium on Clinical and Translational Medicine, May 31, 2014, Beijing. Certificate.
  8. Liang C, Guo B, Wu H, Zhang L, Lu A, Zhang G. Aptamer-Functionalized Lipid Nanoparticles (LNPs) Targeting Osteoblasts as a Novel RNAi-Based Bone Anabolic Strategy. Webster Jee Travel Award. the 7th international Conference on Osteoporosis and Bone Research, Oct 16-19, Xiamen, China.

Award in 2013
  1. Jin Liu, Does age-related increase in CKIP-1 within mesenchymal stem cells associate with age-related impairment in fracture repair ?, Oral Presentation Award (2nd Prize), Postgraduate Research Symposium on Regenerative Medicine 2013, Guangzhou, China, 2013. Certificate.
  2. Biao Liu, Toward targeted therapy in advanced pancreatic cancer: a smart triptolide-nucleolin aptamer conjugate, Oral Presentation Award (3nd Prize), Postgraduate Research Symposium on Regenerative Medicine 2013, Guangzhou, China, 2013. Certificate.